Therapeutics

AP1M1 Knockout Validated to Enhance Antisense Drug Delivery, Guiding Broader RNA Therapy Development

Disruption of AP1M1 extends endosomal retention of antisense drugs, with ongoing tests of its application to broader RNA therapies alongside pathogen interventions.